Dr. Borad is Professor of Medicine at the Mayo Clinic College of Medicine and Science (Phoenix, AZ branch). He is a recognized leader in early-phase and precision oncology clinical trials, particularly for liver and biliary tract cancers. He has extensive experience as a principal investigator on Phase I/II studies, advancing targeted therapies and immunotherapies for rare and refractory malignancies. His work integrates genomic profiling with clinical trial design, enabling biomarker-driven approaches in small patient populations. Dr. Borad brings to the MSAB deep expertise in developing and executing trials for rare cancers, and in leveraging collaborative networks to assess the clinical impact of novel therapies.